Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy. - SWNS Stories

Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy.  SWNS Stories

Pulmocide CEO Garth Rapeport has a long history in biotech research. Heading a team that's developing inhaled medications for viral and fungal infections, ...